非体外循环冠状动脉旁路移植术中升主动脉近端吻合装置与不接触技术的围术期安全性比较
本研究基于日本成人心血管外科数据库2014至2016年数据,采用倾向性评分匹配比较非体外循环冠状动脉旁路移植术中升主动脉近端吻合装置与不接触技术的围术期安全性。结论认为装置临床安全性与不接触技术相当,止血可能是装置使用中实现更高质量控制的关键问题。
要点
- 装置组手术时间显著长于不接触组(293 vs 281分钟,P<.001)。
- 装置组同种异体输血率显著更高(56.9% vs 51.0%,P<.001)。
- 装置组新发房颤显著更常见(11.9% vs 10.3%,P=.01)。
核心结论
- 装置用于CABG近端吻合的临床安全性与不接触技术在死亡率和并发症方面相当。
- 止血可能是装置使用中实现更高质量控制的关键问题。
研究设计与样本
- 基于日本成人心血管外科数据库的回顾性队列研究,纳入2014至2016年接受孤立非体外循环CABG的患者。
- 采用倾向性评分1:1匹配,匹配变量包括患者人口学、合并症、心脏状况和手术特征。
- 装置组9546例,不接触组6890例,匹配后每组各5012例。
主要发现
- 装置组手术时间显著长于不接触组(293 vs 281分钟;P<.001)。
- 装置组同种异体输血显著多于不接触组(56.9% vs 51.0%;P<.001)。
- 装置组新发房颤显著更常见(11.9% vs 10.3%;P=.01)。
- 新启动透析在不接触组更常见(1.4% vs 1.9%;P=.051),因移植血管闭塞再手术在装置组更常见(1.0% vs 0.6%;P=.06),但均未达统计学显著性。
临床怎么用
- 在非体外循环CABG升主动脉近端吻合中,装置可作为一种与不接触技术安全性相当的选择。
- 使用装置时需关注止血管理,因其与更多同种异体输血相关。
- 装置组新发房颤更多,术后应加强心律监测。
局限性
- 研究为回顾性数据库分析,尽管采用倾向性评分匹配,仍可能存在未测量混杂。
- 原文未报告匹配后基线特征的标准化差异等匹配质量指标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We recently reported early postoperative results comparing the use of an anastomosis-assist device with a side-biting clamp for ascending aorta during coronary artery bypass grafting (CABG). Transient neurological complications occurred less often with the device. Here, we evaluated the perioperative safety of the device compared with the aorta no-touch technique (no-touch). METHODS: We evaluated patients listed in the Japan Adult Cardiovascular Surgery Database who received isolated off-pump CABG with either the device or the no-touch approach from 2014 to 2016. We performed a one-to-one matched analysis based on a propensity score modeled from patient demographics, comorbidities, cardiac conditions, and procedural characteristics. We compared early outcomes in both groups using Pearson's chi-square or Wilcoxon rank sum test as appropriate; P less than .05 was statistically significant. RESULTS: Among 9546 device and 6890 no-touch patients, we found 5012 patient matches for each group. The device operation time was significantly longer (293 versus 281 minutes; P < .001) and homologous transfusion was significantly greater (56.9% versus 51.0%; P < .001) than with no-touch. Thirty-day operative mortality (1.5% versus 1.7%; P = .34), morbidity and mortality (6.8% versus 7.5%; P = .17), and stroke (0.9% versus 1.1%; P = .36) were similar in both groups. New-onset atrial fibrillation (11.9% versus 10.3%; P = .01) occurred significantly more often with the device. Newly initiated dialysis (1.4% versus 1.9%; P = .051) was more frequent with no-touch whereas reoperation for graft occlusion was more frequent with the device (1.0% versus 0.6%; P = .06) but was not significant for either outcome. CONCLUSIONS: The clinical safety of use of the device in CABG was comparable to no-touch for mortality and morbidity. Hemostasis may be a key issue for accomplishing higher-level quality control when devices are used in proximal anastomosis of CABG.
引用
- Saito A, Kumamaru H, Miyata H, et al. Device Use for Proximal Anastomosis on Ascending Aorta in Off-Pump Coronary Artery Bypass Grafting. Ann Thorac Surg. 2020. PMID: 33065052. doi:10.1016/j.athoracsur.2020.08.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。